Pepsinogens: Physiology, pharmacology pathophysiology and exercise

Pharmacological Research

Volumn 41, Issue 3, 2000, Pages 265-281

  Gritti, I ^a,b   Banfi, G ^a,c   Roi, G S ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Casa di Cura S Maria   (Italy)

^c Casa Di Cura Santa Maria   (Italy)

Author keywords

Aspartic proteinases; Gastric diseases; High altitude; Marathon; Pepsinogen A; Pepsinogen C

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP; GASTRIN; HYDROCHLORIC ACID; HYDROCORTISONE; PEPSIN A; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II; PROTEIN KINASE C;

CALCIUM CELL LEVEL; CIRCADIAN RHYTHM; ENZYME MODIFICATION; EXERCISE; FEEDBACK SYSTEM; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW;

EID: 0033836701     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0586     Document Type: Article

References (123)

1. Ueber das wesen des verdauungs prozessen
2. On the histology and physiology of pepsin-forming glands
3. Pepsinogen and pepsin
4. Studies on gastric proteolysis. III. The secretion of different pepsins by fundic and pyloric glands of the stomach
5. Gastric proteolysis in disease. IV. Proteinase activity of extracts of human gastric adenocancinomata
6. The pepsins of patients with peptic ulcer
7. Peptic ulcer: The many proteinases of aggression
8. Pepsin
9. Aspartic proteinases
10. Cellular basis of pepsinogen secretion
11. Evolution in the structure and function of carboxylic proteases
12. Comparison of four methods for the determination of plasma pepsinogen concentration
13. Pepsinogens in health and disease
14. Immunocytochemistry and in situ hybridisation studies of pepsinogenic C-producing cell in developing rat fundic glands
15. Secretion of pepsinogen
16. 2+ ](i) in single cells
17. Exocytosis in isolated gastric glands induced by secretagogues and hyperosmolarity
18. Quantitative ultrastructural studies on rat gastric zymogen
19. Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells
20. + and pepsin secretion and serum group I pepsinogen
21. 2. Biochemical and functional characterisation
22. Muscarinic receptors in isolated gastric fundic mucosal cells
23. 2) controlling acid secretion in rodents
24. Characteristics of two biochemical responses to stimulation of muscarinic receptors
25. Positive modulation of pepsinogen secretion by gastric acidity after vagal cholinergic stimulation
26. 2 receptor that inhibits pepsin secretion in the dog
27. + and pepsin secretion in dogs
28. Regulation of pepsin secretion by topical acid in the stomach
29. Lack of interaction between acid and pepsinogen secretion in isolated gastric glands
30. Pepsinogen release from isolated gastric glands
31. Pepsinogen secretion by frog esophagus in vitro
32. Bombesin induced pepsinogen secretion from frog esophagus peptic glands in vitro
33. Adrenergic stimulation of pepsinogen release from rabbit isolated gastric glands
34. The pharmacology of β-2-selective adrenoreceptor antagonist (ICI-118,551)
35. Atypical characteristic of the β-adrenoreceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte
36. Preliminary studies on SL75212, a new potent cardioselective β-adrenoreceptor antagonist
37. cAMP and secretagogue interactions in isolated gastric glands
38. Role of peripheral GABAb receptors in the regulation of pepsinogen secretion in anaesthetized rats
39. Stimulation of pepsinogen release from isolated gastric glands by cholecystokinin-like peptides
40. Central administration of cholecistokinin stimulates gastric pepsinogen secretion from anaesthetized rats
41. Characterization of CCK(a) receptor mediated pepsinogen secretion in porcine chief cells
42. The effect of secretin on serum group I Pepsinogens in man
43. Relation of gastric acid and pepsin secretions to serum gastrin levels in dogs given bombesin and gastrin-17
44. Effects of truncal vagotomy and antrectomy an bombesin-stimulated pancreatic secretion, release of gastrin and pancreatic polypeptide in the anesthetized dog
45. Somatostatin inhibition of pepsinogen release from canine chief cells in primary culture
46. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agent that increase cAMP and phospholiphase C
47. Purification and properties of rabbit skeletal muscle adenosine 3-5 monophosphate-dependent protein kinase
48. Stimulation of pepsinogen secretion in permeable isolated gastric glands
49. 2+/calmodulin with protein kinase C
50. 2 on cyclicAMP production by isolated canine fundic mucosal cells
51. Sulfonylurea effects on acid and pepsinogen secretion in isolated rabbit gastric glands
52. 2+ and elevation of inositol triphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa
53. Potentiation of pepsinogen secretion from dispersed glands from rat stomach
54. Effects of inositol-1,4,5-triphosphate on isolated subcellular fractions of rat pancreas
55. 2+ from a non-mitochondrial intracellular store in pancreatic acinar cells by inositol 1,4,5-triphosphate
56. Inositol triphosphate and diacylglycerol as intracellular second messengers in liver
57. Stimuli of pepsinogen secretion from frog isolated peptic cells
58. Combined effect of phorbol ester and A23187 or dibutyril cyclic AMP on pepsinogen secretion from isolated gastric glands
59. 2+/calmodulin-dependent protein kinase II
60. Nitric Oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells
61. 2 receptors antagonizing pepsinogen secretion of porcine chief cells
62. Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by nitric oxide-dependent pathway
63. Structures and activities of protease inhibitors of microbial origin
64. Low-molecular-weight enzyme inhibitors of microbial origin
65. The inactivation by carbenoxolone of individual human pepsinogens and pepsins
66. Agents for control of gastric acidity and treatment of peptic ulcers
67. The influence of various secretory inhibitors on peptic activity
68. Pepsinogen in gastric juice, blood and urine after proximal selective vagotomy and administration of pirenzepine or cimetidine
69. Serum pepsinogen after bolus i.v. injection of pirenzepine in healthy subjects and after oral administration in duodenal ulcer patients
70. + ATPase inhibitors, anticholinergic agents, anti-depresants, and gastrin receptor antagonists as gastric acid antisecretory agents
71. Total and group I serum pepsinogen after ranitidine and cimetidine injection
72. Ulcer healing and serum pepsinogen in cimetidine and glycopyrolate treated duodenal ulcer patients
73. Effect of 1 month treatment with cimetidine on gastric secretion and serum and pepsinogen levels
74. Serum pepsinogen in normal subjects and in peptic ulcer and its modification after Ranitidine treatment
75. Measurements of aspartic proteinases in endoscopic gastroduodenal biopsies
76. Effect of omeprazole, a gastric proton pump inhibitor, on pentagastrin stimulated acid secretion in man
77. Repeated intravenous bolus injections of omeprazole effects on 24-h intragastric pH serum gastrin, and serum pepsinogen A and C
78. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels
79. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric secretion
80. Effects of long treatments with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis
81. Weekend treatment with 20 and 40 mg omeprazole: Effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens
82. Effects of oral omeprazole on serum gastrin and pepsinogen I levels
83. Dissociations of pepsinogen and acid secretion in guinea pig
84. +-ATPase and in pepsinogen-rich fractions from rabbit gastric mucosa
85. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man
86. Effects of Omeprazole treatment on plasma concentrations of the gastric peptides, xenin, gastrin and somatostatin, and of pepsinogen
87. Gastroduodenale vertraglichkeit und klinische wirksamkeit der therapie mit lanazolac-calcium bei rheumatischen erkrankungen
88. Effecto de la indometacina sobre la secrecion de pepsinogeno en celulas humanas aisladas in vitro
89. Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells
90. Determination of pepsinogens I in serum by radioimmunoassay
91. Pepsinogens and gastrointestinal symptoms in mountain marathon runners
92. Radioimmunoassay of human pepsinogen A and pepsinogen C
93. Serum gastrin, pepsinogens, parietal cell and Helicobacter pylori antibodies in patients with gastric polyps
94. Pepsinogen A and C: Purification from human gastric mucosa and determination in serum by optimized radioimmunoassays
95. Enzyme-linked immunoadsorbent assay of serum pepsinogen I
96. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders
97. Radioimmunoassay of group II pepsinogen in human serum
98. Variability in serum pepsinogen levels in an asymptomatic population
99. An enzyme immunoassay for pepsinogen II (PGII): Chronological changes in serum PGII concentrations
100. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II, I
101. Radioimmunological quantitation of human group II pepsinogens
102. Changes in serum pepsinogen, gastrin, and immunoglobulin G antibody titers in helicobacter pylory-positive gastric ulcer after eradication of infection
103. Radioimmunoassay for pepsinogen C
104. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer
105. Serum pepsinogens I and II and gastric mucosal hystology after partial gastrectomy
106. Serological tests to monitor treatment of Helicobacter pylori
107. Gastrointestinal disorders in runners
108. Gastrointestinal disturbances in marathon runners
109. Physiological changes and gastro-intestinal symptoms as a result of ultra endurance running
110. Abdominal complains and gastrointestinal function during long lasting exercise
111. The gastrointestinal symptoms of running
112. Is hypergastrinaemia dangerous for man?
113. Is hypergastrinaemia dangerous to man?
114. Is the gut an athletic organ?
115. Usefulness of free testosterone/cortisol ratio during a season of elite speed skating athletes
116. Cortisol, testosterone and free testosterone in athletes performing a marathon at 4000 m of altitude
117. Plasma hormones and physical exercise
118. Central autonomic system